Welcome to LookChem.com Sign In|Join Free

CAS

  • or

139-33-3

Post Buying Request

139-33-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

139-33-3 Usage

Description

Ethylenediaminetetra-acetic acid (abbreviated as EDTA) is used in several industrial applications attributing to its high ability to bind to most of metal cations. EDTA is produced as several salts, e.g. ethylenediaminetetra-acetic acid disodium salt (EDTAS). EDTA and its salts are used as chelating agents in cosmetic formulations. EDTAS is a preservative, sequestrant, and stabilizer in foods. EDTA is added to ascorbic acid-disodium benzoate containing soft drinks to mitigate the formation of benzene. EDTA and its salts are used as a component in the production of food-contact paper and paperboard. EDTAS is permitted in the feed and drinking water of animals and/or for the treatment of food-producing animals. In the textile industry, EDTA and its salts prevent metal ion impurities from changing colors of dyed products. In the pulp and paper industry, EDTA and its salts inhibit the ability of metal ions from catalyzing the disproportionation of hydrogen peroxide (a typical bleaching agent). EDTAS is used in synthetic rubber manufacture. EDTAS is also used as a corrosion inhibitor to carbon steel in the industries. As an anticoagulant, EDTAS and tripotassium salts of EDTA are most commonly used.

uses

Ethylenediaminetetraacetic acid (EDTA) is an aminopolycarboxylic acid and a hexadentate ligand. It chelates with metal ions, especially with cations to form an octahedral complex. Ethylenediaminetetraacetic acid disodium salt (EDTA) is a blood anticoagulant and contributes to the pathogenesis of pseudothrombocytopenia. It chelates with calcium in the blood and inhibits clotting and is routinely used in haematological tests. It enhances the antibacterial activity of lysozyme. EDTA used in chelation therapy chelates with calcium and favors dilation of artery, solubilisation of atheromatous plaques in atherosclerotic vascular disease. EDTA chelation therapy may also protect from oxidative damage during blood and lipid peroxidation in liver fibrosis.

References

[1] Victor O. Sheffel (2000) Indirect Food Additives and Polymers: Migration and Toxicology. [2] Lanigan RS, Yamarik TA (2002) Final report on the safety assessment of EDTA, calcium disodium EDTA, diammonium EDTA, dipotassium EDTA, disodium EDTA, TEA-EDTA, tetrasodium EDTA, tripotassium EDTA, trisodium EDTA, HEDTA, and trisodium HEDTA, Int J Toxicol., 21, 95-142

Chemical Properties

Disodium edetate occurs as a white crystalline, odorless powder with a slightly acidic taste.

Originator

Endrate Disodium,Bersworth,US,1959

Uses

Different sources of media describe the Uses of 139-33-3 differently. You can refer to the following data:
1. disodium EDTA is a preservative used in concentrations of 0.1 to 0.5 percent.
2. Disodium Dihydrogen EDTA is a sequestrant and chelating agent whose complete name is disodium ethylenediamine tetraacetate. it is a nonhygroscopic powder that is colorless, odorless, and tasteless at recommended use levels. A 1% solution has a ph of 4.3–4.7. It is used to control the reaction of trace metals to include calcium and magnesium with other organic and inorganic components in food to prevent deterioration of color, texture, and development of precipitates and to prevent oxidation. Its function is comparable to that of disodium calcium edta.
3. Chelating agent (metal); pharmaceutic aid (chelating agent).
4. Ethylenediaminetetraacetic acid disodium salt is widely used in textile industry. Usually applied to dissolve limescale. It is applied in textile industry, pulp and paper industry and also in chelation therapy. In cosmetics, it acts as a sequestering agent. It acts as a corrosion inhibitor to carbon steel in the industries. It also acts as a food additive.

Definition

ChEBI: An organic sodium salt that is the anhydrous form of the disodium salt of ethylenediaminetetraacetic acid (EDTA).

Application

Ethylenediaminetetraacetic acid disodium salt dihydrate has been in seed germination trials of plant species and in protein extraction from Moss, Physcomitrella paten. It has also been used in lysis and vacuole buffer for the isolation of vacuoles from Petunia petals.Chelator of divalent cations. Inhibits enzymes, such as metalloproteases, that require divalent cations for activity.

Production Methods

Disodium edetate may be prepared by the reaction of edetic acid and sodium hydroxide.

Manufacturing Process

10 mols of ethylene diamine as a 30% aqueous solution and 4 mols of solid caustic soda are placed in a steam heated kettle supplied with an agitator. 8 mols of sodium cyanide as a concentrated water solution (about 30%) are added and the solution heated to 60°C. About a 10 inch vacuum is applied to bring the liquid to incipient boiling. Formaldehyde (7.5 mols of 37% to 40% aqueous solution) is slowly added, the temperature being held at 60°C, and the solution vigorously stirred. Then, when the evolution of ammonia has substantially stopped, an additional 8 mols of sodium cyanide, followed by 8 mols of formaldehyde are added as before. This is continued until 40 mols of cyanide and 40 mols of formaldehyde have been added. Then at the end about 2 mols more of formaldehyde are added, making 42 mols in all, to remove any last traces of cyanide. About 8 to 10 hours are required to complete the reaction. The resulting product, referred to herein as the crude reaction product, is essentially an aqueous solution of the sodium salt of ethylene diamine tetracetic acid.To 1,000 g of the crude reaction product are added 264 g of ethylene diamine tetracetic acid. The mixture is preferably heated to incipient boiling to increase the rate of reaction, and then the mixture is allowed to cool and crystallize. The crystals formed are filtered off, washed with the smallest possible amount of ice water, and dried to a constant weight, which is 452 g. A representative sample of the product so prepared showed, upon analysis, 13.26% sodium against a theoretical of 13.70% for the disodium salt. The dialkali salt has a pH of about 5.3 and behaves like a weak acid, displacing CO2 from carbonates and reacting with metals to form hydrogen. It is a white crystalline solid.

Brand name

Endrate (Hospira); Sodium Versenate (3M Pharmaceuticals).

Therapeutic Function

Pharmaceutic aid (chelating agent)

General Description

Ethylenediamine tetraacetate (EDTA) is a calcium ion chelator, that has a low molecular mass of 292.24 Da.

Flammability and Explosibility

Nonflammable

Pharmaceutical Applications

Disodium edetate is used as a chelating agent in a wide range of pharmaceutical preparations, including mouthwashes, ophthalmic preparations, and topical preparations, typically at concentrations between 0.005 and 0.1% w/v. Disodium edetate forms stable water-soluble complexes (chelates) with alkaline earth and heavy-metal ions. The chelated form has few of the properties of the free ion, and for this reason chelating agents are often described as ‘removing’ ions from solution, a process known as sequestering. The stability of the metal–edetate complex is dependent on the metal ion involved and the pH. Disodium edetate is also used as a water softener as it will chelate calcium and magnesium ions present in hard water. It is also used therapeutically as an anticoagulant as it will chelate calcium and prevent the coagulation of blood in vitro. Concentrations of 0.1% w/v are used in small volumes for hematological testing and 0.3% w/v in transfusions.

Biochem/physiol Actions

Ethylenediaminetetraacetic acid disodium salt has the ability to block the binding of vasoactive intestinal peptide to macrophage membranes. It is mainly used in the purification of protein, to remove divalent cations and also to prevent protease activity.

Safety Profile

Poison by intraperitoneal and intravenous routes. Moderately toxic by ingestion. Experimental teratogenic and reproductive effects. Mutation data reported. The calcium disodium salt of EDTA is used as a chelating agent in treating lead poisoning. When heated to decomposition it emits toxic fumes of NOx and NasO.

Safety

Disodium edetate is used widely in topical, oral, and parenteral pharmaceutical formulations; it is used extensively in cosmetic and food products. Disodium edetate and edetate calcium disodium are used in a greater number and variety of pharmaceutical formulations than is edetic acid. Both disodium edetate and edetate calcium disodium are poorly absorbed from the gastrointestinal tract and are associated with few adverse effects when used as excipients in pharmaceutical formulations. Disodium edetate, trisodium edetate, and edetic acid readily chelate calcium and can, in large doses, cause calcium depletion (hypocalcemia) if used over an extended period of time, or if administered too rapidly by intravenous infusion. If used in preparations for the mouth, they can also leach calcium from the teeth. However, edetate calcium disodium does not chelate calcium. Disodium edetate should be used with caution in patients with renal impairment, tuberculosis, and impaired cardiac function. Although disodium edetate is generally considered safe, there have been reports of disodium edetate toxicity in patients receiving chelation therapy. Nasal formulations containing benzalkonium chloride and disodium edetate, both known to be local irritants, were shown to produce an inflammatory reaction, and microscopic examination showed an extended infiltration of the mucosa by eosinophils, and pronounced atrophy and disorganization of the epithelium, although these effects were subsequently shown to be reversible. The WHO has set an estimated acceptable daily intake for disodium EDTA in foodstuffs of up to 2.5 mg/kg body-weight LD50 (mouse, IP): 0.26 g/kg LD50 (mouse, IV): 0.056 g/kgLD50 (mouse, OP): 2.05 g/kg LD50 (rabbit, IV): 0.047 g/kg LD50 (rabbit, OP): 2.3 g/kg LD50 (rat, OP): 2.0 g/kg

Veterinary Drugs and Treatments

Edetate Disodium (Sodium EDTA) is a chelating agent that is also used to stop the melting effect of collagenases and proteases on the cornea. EDTA is useful in halting melting through inhibition of matrix metalloproteinases, but is not felt to be useful for melting caused by infectious agents. As the effect of EDTA on metalloproteinases is reversible, it must be administered several times daily to be effective.

storage

Edetate salts are more stable than edetic acid (see also Edetic acid). However, disodium edetate dihydrate loses water of crystallization when heated to 120°C. Aqueous solutions of disodium edetate may be sterilized by autoclaving, and should be stored in an alkali-free container. Disodium edetate is hygroscopic and is unstable when exposed to moisture. It should be stored in a well-closed container in a cool, dry place.

Incompatibilities

Disodium edetate behaves as a weak acid, displacing carbon dioxide from carbonates and reacting with metals to form hydrogen. It is incompatible with strong oxidizing agents, strong bases, metal ions, and metal alloys.

Regulatory Status

GRAS listed. Included in the FDA Inactive Ingredients Database (inhalations; injections; ophthalmic preparations; oral capsules, solutions, suspensions, syrups, and tablets; rectal topical, and vaginal preparations). Included in nonparenteral and parenteral medicines licensed in the UK. Included in the Canadian List of Acceptable Non-medicinal Ingredients.

Check Digit Verification of cas no

The CAS Registry Mumber 139-33-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,3 and 9 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 139-33:
(5*1)+(4*3)+(3*9)+(2*3)+(1*3)=53
53 % 10 = 3
So 139-33-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H16N2O8.2Na/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20;;/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20);;/q;2*+1

139-33-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (39781)  Ethylenediaminetetraacetic acid disodium salt, 0.100N (0.050M) Standardized solution   

  • 139-33-3

  • 1L

  • 263.0CNY

  • Detail
  • Alfa Aesar

  • (39781)  Ethylenediaminetetraacetic acid disodium salt, 0.100N (0.050M) Standardized solution   

  • 139-33-3

  • 4L

  • 572.0CNY

  • Detail
  • Alfa Aesar

  • (39782)  Ethylenediaminetetraacetic acid disodium salt, 0.115N (0.0575M) Standardized solution   

  • 139-33-3

  • 1L

  • 167.0CNY

  • Detail
  • Alfa Aesar

  • (39782)  Ethylenediaminetetraacetic acid disodium salt, 0.115N (0.0575M) Standardized solution   

  • 139-33-3

  • 4L

  • 444.0CNY

  • Detail
  • Alfa Aesar

  • (39783)  Ethylenediaminetetraacetic acid disodium salt, 0.200N (0.1M) Standardized solution   

  • 139-33-3

  • 1L

  • 372.0CNY

  • Detail
  • Alfa Aesar

  • (39783)  Ethylenediaminetetraacetic acid disodium salt, 0.200N (0.1M) Standardized solution   

  • 139-33-3

  • 4L

  • 1072.0CNY

  • Detail
  • Fluka

  • (38057)  Ethylenediaminetetraacetic acid disodium salt concentrate  for 1L standard solution, 0.1 M EDTA-Na2, for complexometry

  • 139-33-3

  • 38057-1EA

  • 383.76CNY

  • Detail
  • Fluka

  • (38057)  Ethylenediaminetetraacetic acid disodium salt concentrate  for 1L standard solution, 0.1 M EDTA-Na2, for complexometry

  • 139-33-3

  • 38057-6X1EA

  • 2,004.21CNY

  • Detail
  • Fluka

  • (35102)  Ethylenediaminetetraaceticaciddisodiumsaltsolution  volumetric, 0.2 M EDTA-Na2, for complexometry

  • 139-33-3

  • 35102-1L

  • 1,105.65CNY

  • Detail
  • Fluka

  • (35102)  Ethylenediaminetetraaceticaciddisodiumsaltsolution  volumetric, 0.2 M EDTA-Na2, for complexometry

  • 139-33-3

  • 35102-5L-VP

  • 1,346.67CNY

  • Detail
  • Fluka

  • (35102)  Ethylenediaminetetraaceticaciddisodiumsaltsolution  volumetric, 0.2 M EDTA-Na2, for complexometry

  • 139-33-3

  • 35102-10L-VP

  • 1,709.37CNY

  • Detail
  • Fluka

  • (34550)  Ethylenediaminetetraaceticaciddisodiumsaltsolution  Reag. Ph. Eur., volumetric, 0.1 M EDTA-Na2, for complexometry

  • 139-33-3

  • 34550-500ML-R

  • 294.84CNY

  • Detail

139-33-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name EDTA disodium salt (anhydrous)

1.2 Other means of identification

Product number -
Other names cheladrate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:139-33-3 SDS

139-33-3Synthetic route

4,5-Di-O-isopropylidene-D-erythro-2,3-hexodiuro-2,6-pyranose

4,5-Di-O-isopropylidene-D-erythro-2,3-hexodiuro-2,6-pyranose

Oxone

Oxone

(E)-1,2-diphenyl-ethene
103-30-0

(E)-1,2-diphenyl-ethene

edetate disodium
139-33-3

edetate disodium

(R,R)-trans-stilbene epoxide
1439-07-2

(R,R)-trans-stilbene epoxide

Conditions
ConditionsYield
With sodium hydrogencarbonate; triethylamine; tetra(n-butyl)ammonium hydrogen sulfate In hexane; acetonitrile95.2%
With sodium hydrogencarbonate; triethylamine; tetra(n-butyl)ammonium hydrogen sulfate In hexane; acetonitrile95.2%
N-<3-<(mercaptocetyl)amino>benzoyl>glycine
67852-72-6

N-<3-<(mercaptocetyl)amino>benzoyl>glycine

edetate disodium
139-33-3

edetate disodium

N-[3-(Mercaptoacetylamino)benzoyl]-glycine Potassium Salt Hydrate

N-[3-(Mercaptoacetylamino)benzoyl]-glycine Potassium Salt Hydrate

Conditions
ConditionsYield
With potassium hydroxide In tetrahydrofuran; water93%
With potassium hydroxide In tetrahydrofuran; water93%
edetate disodium
139-33-3

edetate disodium

Ethylenediaminetetra-acetic acid N,N'-dioxide
3055-19-4

Ethylenediaminetetra-acetic acid N,N'-dioxide

Conditions
ConditionsYield
With sodium hydroxide; 3-chloro-benzenecarboperoxoic acid Ambient temperature;80%
N-<3-<(mercaptocetyl)amino>benzoyl>glycine
67852-72-6

N-<3-<(mercaptocetyl)amino>benzoyl>glycine

edetate disodium
139-33-3

edetate disodium

N-[3-(mercaptoacetylamino)benzoyl]glycine ammonium salt

N-[3-(mercaptoacetylamino)benzoyl]glycine ammonium salt

Conditions
ConditionsYield
With ammonium hydroxide In tetrahydrofuran79.3%
With ammonium hydroxide In tetrahydrofuran79.3%
CuCO3.Cu(OH)2.H2O

CuCO3.Cu(OH)2.H2O

piperazine-2-carboxylic acid dihydrochloride
3022-15-9, 126330-90-3, 133525-05-0, 135841-26-8

piperazine-2-carboxylic acid dihydrochloride

edetate disodium
139-33-3

edetate disodium

4-nitrobenzyl chloroformate
4457-32-3

4-nitrobenzyl chloroformate

piperazine-1,3-dicarboxylic acid 1-(4-nitrobenzyl)ester
623565-10-6

piperazine-1,3-dicarboxylic acid 1-(4-nitrobenzyl)ester

Conditions
ConditionsYield
With hydrogenchloride; sodium hydrogencarbonate In 1,4-dioxane; water77%
Tetrahydrothiopyran-4-one
1072-72-6

Tetrahydrothiopyran-4-one

edetate disodium
139-33-3

edetate disodium

1,1-dioxotetrahydrothiopyran-4-one
17396-35-9

1,1-dioxotetrahydrothiopyran-4-one

Conditions
ConditionsYield
With oxone; sodium hydrogencarbonate In acetonitrile73%
sodium tungstate (VI) dihydrate
10213-10-2

sodium tungstate (VI) dihydrate

phosphoric acid
86119-84-8, 7664-38-2

phosphoric acid

copper(II) acetate monohydrate
6046-93-1

copper(II) acetate monohydrate

edetate disodium
139-33-3

edetate disodium

4Na(1+)*OH(1-)*2Cu(2+)*(CH2N(CH2CO2)2)2(4-)*PW12O40(3-)*17H2O=Na4(OH)(Cu2(CH2N(CH2CO2)2)2)PW12O40*17H2O

4Na(1+)*OH(1-)*2Cu(2+)*(CH2N(CH2CO2)2)2(4-)*PW12O40(3-)*17H2O=Na4(OH)(Cu2(CH2N(CH2CO2)2)2)PW12O40*17H2O

Conditions
ConditionsYield
In hydrogenchloride; water; sodium chloride Na2WO4*2H2O dissolved in H2O, heated to 90°C for 10 min, H3PO4 dissolved in aq. HCl and Cu(CH3CO2)2*H2O dissolved in satd. NaCl soln. added, pH adjusted to 3.33, kept at 90°C for 1 h, Na-salt added, stirred for 1 h, cooled to room temp.; filtered, filtrate retained in room temp. for 16 d; elem. anal.;54%
sodium tungstate (VI) dihydrate
10213-10-2

sodium tungstate (VI) dihydrate

sodium metasilicate nonahydrate

sodium metasilicate nonahydrate

copper(II) acetate monohydrate
6046-93-1

copper(II) acetate monohydrate

edetate disodium
139-33-3

edetate disodium

4Na(1+)*2Cu(2+)*(CH2N(CH2CO2)2)2(4-)*SiW12O40(4-)*19H2O=Na4(Cu2(CH2N(CH2CO2)2)2)SiW12O40*19H2O

4Na(1+)*2Cu(2+)*(CH2N(CH2CO2)2)2(4-)*SiW12O40(4-)*19H2O=Na4(Cu2(CH2N(CH2CO2)2)2)SiW12O40*19H2O

Conditions
ConditionsYield
In hydrogenchloride; water; sodium chloride Na2WO4*2H2O dissolved in H2O, heated to 90°C for 10 min, Na2SiO3 dissolved in aq. HCl and Cu(CH3CO2)2*H2O dissolved in satd. NaCl soln. added, pH adjusted to 3.33, kept at 90°C for 1 h, Na-salt added, stirred for 1 h, cooled to room temp.; filtered, filtrate retained in room temp. for 16 d; elem. anal.;50%
potassium pentachloronitrosylruthenate(III)

potassium pentachloronitrosylruthenate(III)

water
7732-18-5

water

edetate disodium
139-33-3

edetate disodium

Ru(H2edta)(NO)Cl*1.5H2O

Ru(H2edta)(NO)Cl*1.5H2O

Conditions
ConditionsYield
In hydrogenchloride Na2EDTA was suspended in aq. HCl, heated to reflux, soln. of Ru-complex in aq. HCl was added, heated to reflux for 18 h; filtered, solvent was removed in vacuo, dissolved in water, passed through Dowex column, collected, solvent was removed in vacuo, dried in vacuoat room temp.; elem. anal.;43.8%
paraquat dichloride
1910-42-5

paraquat dichloride

edetate disodium
139-33-3

edetate disodium

methyl viologen cation radical
26985-31-9

methyl viologen cation radical

Conditions
ConditionsYield
With dinitrogen monoxide In water Rate constant; Irradiation; variation of MV2+ concentration, pH, mode and dose of γ-irradiation; reactivity of EDTA radicals toward methylviologen;
edetate disodium
139-33-3

edetate disodium

ethylenediamine-N,N,N'-triacetic acid
688-57-3

ethylenediamine-N,N,N'-triacetic acid

Conditions
ConditionsYield
With sodium hydroxide; ammonium ferric sulfate; oxygen In water for 168h; Heating;
edetate disodium
139-33-3

edetate disodium

C10H12N2O10(4-)*4Na(1+)

C10H12N2O10(4-)*4Na(1+)

Conditions
ConditionsYield
With sodium hydroxide; dihydrogen peroxide In water at 60℃; for 4h; pH 9;
edetate disodium
139-33-3

edetate disodium

A

formaldehyd
50-00-0

formaldehyd

B

formic acid
64-18-6

formic acid

C

CO2

CO2

Conditions
ConditionsYield
With perchloric acid; peroxomonophosphoric acid In water at 45℃; Kinetics; Thermodynamic data; LiClO4, Cu(II), Fe(II) and phosphate, other temperature, E(activ);
edetate disodium
139-33-3

edetate disodium

A

carbon dioxide
124-38-9

carbon dioxide

B

sodium carbonate
497-19-8

sodium carbonate

C

NaNO3

NaNO3

Conditions
ConditionsYield
With ozone at 20℃; Mechanism; Rate constant; Thermodynamic data; variation in pH, acidity of solution, and temperature; activation energy;
edetate disodium
139-33-3

edetate disodium

NO, CO2, H2O

NO, CO2, H2O

Conditions
ConditionsYield
With oxygen; platinum In gas at 900℃; Product distribution;
edetate disodium
139-33-3

edetate disodium

Cu(II)*EDTA
135179-45-2

Cu(II)*EDTA

Conditions
ConditionsYield
With copper(II) carbonate In water
edetate disodium
139-33-3

edetate disodium

iron(II) sulfate

iron(II) sulfate

ferrous ethylenediamine tetraacetate
21393-59-9

ferrous ethylenediamine tetraacetate

Conditions
ConditionsYield
With tartaric acid; sodium hydroxide In water
In water at 20℃; Heating / reflux;
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

edetate disodium
139-33-3

edetate disodium

2-(benzo[d]isoxazol-3-yl)acetic acid
4865-84-3

2-(benzo[d]isoxazol-3-yl)acetic acid

Conditions
ConditionsYield
Stage #1: 4-hydroxy[1]benzopyran-2-one; edetate disodium With sodium hydroxide; hydroxylamine sulfate In water; 1,2-dichloro-ethane at 84 - 86℃; for 4h;
Stage #2: With sulfuric acid In water pH=1 - 2; Product distribution / selectivity;
5-chloro-1,1,3,3-tetrafluoro-1,3-dihydroisobenzofuran-6-yl-hydrazine

5-chloro-1,1,3,3-tetrafluoro-1,3-dihydroisobenzofuran-6-yl-hydrazine

edetate disodium
139-33-3

edetate disodium

2-Chloroacrylonitrile
920-37-6

2-Chloroacrylonitrile

5-amino-1-(6-chloro-1,1,3,3-tetrafluoro-1,3-dihydroisobenzofuran-5-yl)pyrazole

5-amino-1-(6-chloro-1,1,3,3-tetrafluoro-1,3-dihydroisobenzofuran-5-yl)pyrazole

Conditions
ConditionsYield
With sulfuric acid; sodium carbonate In methanol; water
concentrated aqueous sodium chloride

concentrated aqueous sodium chloride

2,3,6-trichloro-4-trifluoromethyl-phenyl-hydrazine
86399-01-1

2,3,6-trichloro-4-trifluoromethyl-phenyl-hydrazine

edetate disodium
139-33-3

edetate disodium

2-Chloroacrylonitrile
920-37-6

2-Chloroacrylonitrile

5-amino-1-(2,3,6-trichloro-4-trifluoro-methyl-phenyl)-pyrazole
104924-77-8

5-amino-1-(2,3,6-trichloro-4-trifluoro-methyl-phenyl)-pyrazole

Conditions
ConditionsYield
With sulfuric acid; sodium carbonate In methanol; dichloromethane; water
N-<3-<(mercaptocetyl)amino>benzoyl>glycine
67852-72-6

N-<3-<(mercaptocetyl)amino>benzoyl>glycine

edetate disodium
139-33-3

edetate disodium

N-<3-<(mercaptocetyl)amino>benzoyl>glycine ethylenediamine bissalt
67852-77-1

N-<3-<(mercaptocetyl)amino>benzoyl>glycine ethylenediamine bissalt

Conditions
ConditionsYield
With ethylenediamine In tetrahydrofuran; water
With ethylenediamine In tetrahydrofuran; water
lead(II) sulfide

lead(II) sulfide

edetate disodium
139-33-3

edetate disodium

A

Pb(2+)*2H(1+)*(O2CCH2)2NC2H4N(CH2CO2)2(4-)=Pb((O2CCH2)(HO2CCH2)NC2H4N(CH2CO2H)(CH2CO2))

Pb(2+)*2H(1+)*(O2CCH2)2NC2H4N(CH2CO2)2(4-)=Pb((O2CCH2)(HO2CCH2)NC2H4N(CH2CO2H)(CH2CO2))

B

Sulfate
14808-79-8

Sulfate

Conditions
ConditionsYield
With dihydrogen peroxide In water byproducts: H2O; PbS dissolved in aq. soln. contg. H2O2 and Trilon B; incomplete dissolution;
edetate disodium
139-33-3

edetate disodium

vanadium(II) chloride

vanadium(II) chloride

{Vaedt}(2-)

{Vaedt}(2-)

Conditions
ConditionsYield
With sodium hydroxide In water neutralisation of a VCl2-soln. containing Na2H2C2H4(N(CH2COO)2)2-soln. in presence of HCl, NaCl or KCl with NaOH-soln. at glass electrode, equilibrium constants given;;

139-33-3Related news

Chemical spray pyrolysis deposition of zinc sulphide thin films using Ethylenediaminetetraacetic acid disodium salt (cas 139-33-3) complexant10/01/2019

Zinc sulphide thin films were deposited by chemical spray pyrolysis technique. The films were deposited at substrate temperatures of 300, 350 and 400 °C using 0.1 M zinc chloride, 0.1 M thiourea and 0.01 M ethylenediaminetetraacetic acid disodium salt (EDTA). The films have moderate transmittan...detailed

139-33-3Relevant articles and documents

Method for preparing ethylene diamine tetraacetic acid disodium

-

Paragraph 0014-0019, (2018/02/04)

The invention discloses a method for preparing ethylene diamine tetraacetic acid disodium by means of a membrane chemical reactor. The method comprises the steps of 1, material feeding, wherein a certain amount of deionized water is put into the membrane chemical reactor, and then liquid sodium hydroxide and ethylene diamine tetraacetic acid are put into the membrane chemical reactor according to the mass ratio of 2:4 at 95 DEG C by eight batches till the pH value of reaction solution is 5; 2, heat insulation, after materials are fed, heat insulation is conducted on the reaction solution at 90 DEG C for 45 min, and the pH value of reaction solution is controlled to be 5. The preparing process is simple, parallel reaction selectivity and safety are high, three wastes are not generated basically during production, the produced ethylene diamine tetraacetic acid disodium powder is pure white, purity is 99.8% or more, and quality is stable.

NOVEL POWDERED POLYMER, PREPARATION METHOD THEREOF AND USE OF SAME AS A THICKENER

-

, (2012/07/14)

Disclosed is a branched or crosslinked anionic polyelectrolyte of at least one monomer having a partially- or totally-salified strong acid function, with at least one neutral monomer and at least one monomer having formula (I), wherein: R represents a linear or branched alkyl radical including between 8 and twenty carbon atoms, and n represents a number greater than or equal to 1 and less than or equal to twenty. Also described is the use thereof as a thickener in topical compositions.

Cleansing foaming lotion

-

, (2008/06/13)

The invention described herein includes a formulation comprising: a structurant and an emulsion comprising a homogenized mixture of wax and alcohol components, at least one of which is a surfactant, wherein the formulation comprises a stable lamellar or spherulite phase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 139-33-3